Fundraising Fox
Huxley Medical
Atlanta, US · Founded 2019 · Delaware corporation · 2 known investors
Find your way into Huxley Medical
Each arrow is one introduction. Sign up to fill in the first one.
112 people can intro you to Daniel
Ask Matthew McGirt to introduce you to Daniel Burnham
You →Matthew · together at MiRus™ →Daniel
55 people can intro you to Christopher
Ask Jamie Chen to introduce you to Christopher Hallett
You →Jamie · together at Kardium →Christopher
Sign up to find every way you can get introduced to Huxley Medical
- Your email: who you already know at Huxley Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Huxley Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Huxley develops SANSA, a cellular-enabled chest-worn monitor and diagnostic service that detects obstructive and central sleep apnea and records ECG from a single at-home device. It serves sleep labs, cardiology clinics, and primary care providers with AI-assisted reporting and managed testing logistics.
Founders & leadership
CH
Christopher HallettChief Commercial Officer (CCO)2023–2025Christopher Hallett held the role of Chief Commercial Officer at Huxley Medical, where he co-founded and helped scale the SANSA dual-diagnostic device through commercialization and fundraising. Prior to Huxley, he built commercial teams at CardioFocus, Boston Scientific, Itamar Medical, and Biosense Webster, with expertise spanning electrophysiology, diagnostics, and sleep monitoring.
CL
Christopher LeeExecutive
DB
Daniel BurnhamChief Technology OfficerDaniel Burnham is Chief Technology Officer and advisor at Huxley Medical, which develops cellular-enabled wearable diagnostic devices for sleep and cardiac monitoring. He brings over a decade of experience in medical device product development, regulatory strategy, and engineering, with expertise in FDA approval processes and relevant standards including 62304, 60601, and 14971.
KG
Kenneth GallNamed on SEC filing
DB
Drew BeaverNamed on SEC filing
Board
KJ
WC
William CoxBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$50.7M disclosed across 10 rounds · 2021–2026
▶$11MraisedSep 2026 · 40 investors · Other Health CareRule 506(b)
▶$11MraisedSep 2026 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher LeeExecutive Officer, Director
- Brennan TorstrickExecutive Officer, Director
- Kenneth GallDirector
- Kurt JacobusDirector
- Michael PorterDirector
- William CoxDirector
- Drew BeaverDirector
- Offering amount
- $11.7M
- Amount sold
- $11M
- Minimum investment
- $1.2K
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJun 2026 · 20 investors · Other Health CareRule 506(b)
▶$3MraisedJun 2026 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William CoxDirector
- Brennan TorstrickExecutive Officer, Director
- Kurt JacobusDirector
- Kenneth GallDirector
- Daniel BurnhamExecutive Officer
- Christopher LeeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $1.7K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedFeb 2026 · 58 investors · Other Health CareRule 506(b)
▶$10MraisedFeb 2026 · 58 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BurnhamExecutive Officer
- Michael PorterDirector
- William CoxDirector
- Brennan TorstrickExecutive Officer, Director
- Kenneth GallDirector
- Christopher LeeExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $5K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedSep 2025 · 16 investors · Other Health CareRule 506(b)
▶$1.7MraisedSep 2025 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher LeeExecutive Officer, Director
- Daniel BurnhamExecutive Officer
- Kurt JacobusDirector
- Michael PorterDirector
- William CoxDirector
- Kenneth GallDirector
- Brennan TorstrickExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.7M
- Minimum investment
- $25K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedDec 2024 · 60 investors · Other Health CareRule 506(b)
▶$4.6MraisedDec 2024 · 60 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brennan TorstrickExecutive Officer, Director
- Kurt JacobusDirector
- Christopher HallettExecutive Officer, Director
- Christopher LeeExecutive Officer, Director
- Michael PorterDirector
- William CoxDirector
- Daniel BurnhamExecutive Officer
- Kenneth GallDirector
- Offering amount
- $8M
- Amount sold
- $4.6M
- Minimum investment
- $2K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5.4MraisedApr 2024 · 105 investors · Other Health CareRule 506(b)
▶$5.4MraisedApr 2024 · 105 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael PorterDirector
- William CoxDirector
- Christopher HallettExecutive Officer, Director
- Brennan TorstrickExecutive Officer, Director
- Christopher LeeExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $5.4M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$7.2MraisedJun 2023 · 85 investors · Other Health CareRule 506(b)
▶$7.2MraisedJun 2023 · 85 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris LeeExecutive Officer, Promoter
- Brennan TorstrickExecutive Officer
- Offering amount
- $8.1M
- Amount sold
- $7.2M
- Minimum investment
- $100K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.9MraisedApr 2023 · 52 investors · Other Health CareRule 506(b)
▶$2.9MraisedApr 2023 · 52 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brennan TorstrickExecutive Officer
- Chris LeeExecutive Officer, Promoter
- Offering amount
- $3M
- Amount sold
- $2.9M
- Minimum investment
- $2.4K
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
HellosunriseSunrise develops a wireless single-use sensor and companion iOS/Android app that records the respiratory signal at its source to detect sleep apnea at home in one night. It provides clinical reports that patients can share with their doctor or the company's network of partner sleep specialists for diagnosis and tailored treatment.
MedBridge HealthcareMedBridge operates sleep disorder diagnostic centers and provides integrated sleep laboratory management services to hospitals and healthcare systems. The company combines clinical services with a software platform to manage patient care for sleep disorder diagnosis and treatment.
Companies working in the same space as Huxley Medical.
In the news
Frequently asked questions
- What does Huxley Medical do?
- Huxley develops SANSA, a cellular-enabled chest-worn monitor and diagnostic service that detects obstructive and central sleep apnea and records ECG from a single at-home device. It serves sleep labs, cardiology clinics, and primary care providers with AI-assisted reporting and managed testing logistics.
- Who are Huxley Medical's investors?
- Huxley Medical's investors include Duke Capital Partners, GRA Venture.
- How much funding has Huxley Medical raised?
- Huxley Medical has disclosed $50.7M raised across 10 rounds.
- Where is Huxley Medical headquartered?
- Huxley Medical is headquartered in Atlanta, US.